iRadimed Corporation (NASDAQ:IRMD) to Issue Quarterly Dividend of $0.20

Posted by Chris Copeland on Feb 10th, 2026

iRadimed Corporation (NASDAQ:IRMD – Get Free Report) declared a quarterly dividend on Tuesday, February 10th. Stockholders of record on Monday, February 23rd will be given a dividend of 0.20 per share by the medical equipment provider on Friday, March 6th. This represents a c) dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, February 23rd. This is a 17.6% increase from iRadimed’s previous quarterly dividend of $0.17.

iRadimed has a dividend payout ratio of 34.2% meaning its dividend is sufficiently covered by earnings. Analysts expect iRadimed to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 34.0%.

iRadimed Trading Up 9.3%

Shares of NASDAQ IRMD traded up $8.88 during mid-day trading on Tuesday, hitting $104.85. The company had a trading volume of 114,367 shares, compared to its average volume of 77,833. iRadimed has a 1 year low of $47.48 and a 1 year high of $107.90. The company has a market capitalization of $1.33 billion, a price-to-earnings ratio of 63.55 and a beta of 1.11. The stock’s 50-day moving average price is $97.82 and its 200-day moving average price is $83.09.

iRadimed (NASDAQ:IRMD – Get Free Report) last issued its earnings results on Tuesday, February 10th. The medical equipment provider reported $0.54 EPS for the quarter, topping the consensus estimate of $0.49 by $0.05. iRadimed had a return on equity of 22.93% and a net margin of 26.31%.The business had revenue of $22.69 million during the quarter, compared to the consensus estimate of $21.60 million. iRadimed has set its Q1 2026 guidance at 0.440-0.480 EPS and its FY 2026 guidance at 2.060-2.210 EPS. As a group, equities research analysts forecast that iRadimed will post 1.66 earnings per share for the current year.

About iRadimed

(Get Free Report)

iRadimed Corporation designs, develops and manufactures medical device solutions for MRI environments. The company’s core product line consists of MRI-compatible infusion systems engineered to deliver precise fluid management during magnetic resonance imaging procedures. These devices are crafted to minimize electrical noise and interference, ensuring both patient safety and image clarity in diagnostic and interventional settings.

In addition to infusion pumps, iRadimed offers a range of complementary accessories and monitoring solutions tailored to MRI suites.